Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,877 public trials 411 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Recruiting

China Registry for Genetic / Metabolic Liver Diseases

NCT03131427

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +20 more
Locations
  • Beijing Ditan Hospital Beijing, Beijing Municipality, China
  • Beijing Anzhen Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing YouAn Hospital Beijing, Beijing Municipality, China
View Trial Details
Enrolling by Invitation

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

NCT05368038

Conditions
Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +65 more
Locations
  • Maimonides Medical Center Brooklyn, New York, United States
  • NYU Langone Hospital - Brooklyn Brooklyn, New York, United States
  • North Shore University Hospital Manhasset, New York, United States
  • NYU Langone Health - Tisch Hospital New York, United States
View Trial Details
Enrolling by Invitation

An Extension of SKY-0515 in Participants With Huntington's Disease

NCT07537075

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • The University of Queensland Herston, Queensland, Australia
  • Flinders Medical Centre Adelaide, South Australia, Australia
View Trial Details
Enrolling by Invitation

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +19 more
Locations
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 35 locations
View Trial Details
Enrolling by Invitation

AI Echocardiographic Screening of Cardiac Amyloidosis

NCT06664866

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +13 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Palo Alto Veteran Affairs Hospital Palo Alto, California, United States
  • Northwestern Medicine Chicago, Illinois, United States
  • Providence Heart and Vascular Institute Portland, Oregon, United States
View Trial Details
Enrolling by Invitation

An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

NCT06075537

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +22 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Ann and Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • UNC Children's Research Institute Chapel Hill, North Carolina, United States
View all 29 locations
View Trial Details

Related conditions